Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab | [4] Bortezomib Bortezomib,Cyclophosphamide, Daratumumab, Dexamethasone | [5] Cyclophosphamide
Cyclophosphamide
,Dexamethasone , Bortezomib , Cyclophosphamide , Daratumumab 💬 1. Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
| [3] CD38 CD38,NR3C1, PSMB5 💬 | [16] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 [16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell ... | [1] 28 28 💬1. Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
| ||||||||||||||||||
| 2 | Daratumumab | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬2. Daratumumab
| [1] CD38 CD38 💬2. Daratumumab
| [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | [5] 13 13, 28, 48, 49, 63 💬
| ||||||||||||||||||
| 3 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | [3] Daratumumab Daratumumab,Hyaluronidase, Hyaluronidase (human recombinant) | [4] Hyaluronidase
Hyaluronidase
,Hyaluronidase , Hyaluronidase , Daratumumab 💬 3. Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)
| [1] CD38 CD38 💬3. Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)
| [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | [1] 28 28 💬3. Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)
| ||||||||||||||||||
| 4 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬4. Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)
| [1] CD38 CD38 💬4. Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)
| [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | [1] 28 28 💬4. Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)
| ||||||||||||||||||
| 5 | Daratumumab Injection | [1] Daratumumab Daratumumab | [1] Daratumumab
Daratumumab
💬5. Daratumumab Injection
| [1] CD38 CD38 💬5. Daratumumab Injection
| [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | [3] 28 28, 49, 63 💬
|